Latest News

Result of AGM

RNS Number: 7796Z Physiomics PLC 15 December 2014 Physiomics plc (the "Company") Result of AGM The Company is pleased to announce that all resolutions put to shareholders at the Annual General Meeting held today were duly approved. Enquiries: Physiomics plc Dr Mark Chadwick, CEO +44 (0)1865 784980 WH Ireland Limited Katy Mitchell +44 (0) 161 832 ...

FTSE falls as Astrazeneca, financials slip lower

FTSE indices were firmly south approaching midday, albeit off earlier lows, with a plethora of softer financial, utility, ph...

Operating losses fall at Physiomics

Physiomics has reported that for the year ended 30 June 2014 turnover of the company increased by 12% to 267,903 (2013: 2...

Final Results

RNS Number: 8277W Physiomics PLC 12 November 2014 Physiomics Plc ("Physiomics" or "the Company") Final Results for the year ended 30 June 2014 Chairman's Statement Summary of Results in the year ended 30 June 2014 The turnover of the Company increased by 12% to 267,903 (2013: 240,000). The operating loss reduced by 15% to 465,265 (2013: 548,342). On 30...

All News

15-12-14Result of AGMRNS
17-11-14FTSE falls as Astrazeneca, financials slip lowerStockMarketWire
12-11-14Operating losses fall at PhysiomicsStockMarketWire
12-11-14Final ResultsRNS
04-11-14FTSE up on financials as oily stocks feel Saudi pinchStockMarketWire
04-11-14Disclosure of Large Pharma partner Merck & CoRNS
27-10-14Physiomics extends deal with pharma partnerStockMarketWire
27-10-14Project extension with global pharma companyRNS
13-10-14Holding(s) in CompanyRNS
07-10-14Cardiotox Platform LaunchRNS
29-08-14Holding(s) in CompanyRNS
14-08-14Physiomics wins new deal with global pharmaStockMarketWire
14-08-14New deal with global pharmaRNS
24-07-14Physiomics raises up to £562,500StockMarketWire
24-07-14Issue of EquityRNS
26-06-14Holding(s) in CompanyRNS
12-06-14Physiomics in anticipated new collaboration with DiatechStockMarketWire
12-06-14Anticipated new collaboration with DiatechRNS
20-05-14Holding(s) in CompanyRNS
10-04-14Second validation of Virtual Tumour ClinicalRNS
03-04-14Virtual Tumour Clinical ValidationRNS
14-02-14Physiomics narrows H1 pretax loss to £0.21mStockMarketWire
14-02-14Half Yearly ReportRNS
30-01-14Issue of Equity - ReplacementRNS
30-01-14Physiomics issues shares under SEDAStockMarketWire
30-01-14Issue of EquityRNS
16-01-14Physiomics to work with Dundee UniversityStockMarketWire
16-01-14Dundee University CollaborationRNS
17-12-13Physiomics resolutions passed at AGMStockMarketWire
17-12-13Result of AGMRNS
04-12-13Physiomics wins pharmaceutical contractStockMarketWire
04-12-13Virtual Tumour ProposalRNS
28-11-13Physiomics launches DrugCARD databaseStockMarketWire
28-11-13DrugCARD launchRNS
15-11-13Physiomics narrows FY pretax loss to £0.54mStockMarketWire
15-11-13Final ResultsRNS
11-11-13Physiomics in virtual tumour research collaborationStockMarketWire
11-11-13University of Oxford CollaborationRNS
04-11-13Update on the Virtual Tumour Clinical platformRNS
10-10-13Trends and Targets for 11/10/2013Trends and Targets

RSS feeds

  • Editorial news feed for LSE:PYC Editorial
  • Regulatory news feed for LSE:PYC Regulatory